Polyethylenimine Linear (PEI, MW 40,000): Mechanism, Benchmarks, and Application as a DNA Transfection Reagent

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer widely used for DNA transfection in mammalian cells, consistently achieving 60–80% efficiency in serum-containing media (APExBIO, product page). Its mechanism depends on electrostatic condensation of DNA and endocytosis-mediated uptake, a process compatible with diverse cell types including HEK-293 and CHO-K1 (Roach 2024, Pace Digital Commons). The reagent supports applications from small-scale functional genomics to large-scale recombinant protein production. APExBIO’s K1029 formulation is validated for stability and reproducibility. Recent studies confirm that PEI-based complexes maintain mesoscale size, supporting efficient uptake and minimal cytotoxicity under optimized conditions (Roach 2024). All claims are referenced via stable URLs and authoritative product documentation.

Biological Rationale

Efficient delivery of nucleic acids to mammalian cells is essential for gene function studies, therapeutic screening, and recombinant protein production. Most mammalian cells present negatively charged membranes, resulting in limited uptake of naked DNA. Polyethylenimine (PEI) is a synthetic, polycationic polymer that forms stable complexes with DNA via electrostatic interaction, neutralizing charge and facilitating uptake (Roach 2024). Linear PEI of molecular weight 40,000 is preferred due to its balance of transfection efficiency and reduced cytotoxicity relative to branched forms (MoleculeProbe 2023). The reagent is compatible with serum and a wide range of suspension and adherent cell lines.

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

Linear PEI (MW 40,000) condenses negatively charged DNA into positively charged nanoparticles (typically 100–200 nm diameter) at neutral pH. These complexes interact with cell surface proteoglycans, promoting endocytosis-mediated internalization (Roach 2024, Materials & Methods). Once inside endosomes, PEI’s high buffering capacity ("proton sponge effect") promotes osmotic swelling and endosomal escape, releasing DNA into the cytoplasm. Transfection efficiency is influenced by the N/P ratio (number of PEI nitrogen atoms to DNA phosphate groups), which is typically optimized between 5:1 and 10:1 for most cell lines (APExBIO product data). Linear PEI’s lower branching reduces aggregation and cytotoxicity compared with branched PEI of similar molecular weight.

Evidence & Benchmarks

• Transfection efficiencies of 60–80% have been reported in HEK-293, HEK293T, CHO-K1, HepG2, and HeLa cells under serum conditions using linear PEI (MW 40,000) (APExBIO).
• PEI–DNA complexes with diameters between 100–200 nm retain mesoscale size in FBS-containing media, facilitating efficient uptake and kidney targeting (Roach 2024, Table 2).
• Cytotoxicity screens (MTT assay) show cell viability >80% at N/P ratios ≤10:1 over 24–48 h exposure in HEK-293 cells (Roach 2024, Results).
• PEI-mediated gene delivery supports transient recombinant protein yields up to 200 mg/L in 1–100 L bioreactor formats (MoleculeProbe 2023).
• DNA uptake and gene expression have been confirmed via qPCR and fluorescence microscopy in multiple cell types using the K1029 kit (APExBIO).

Applications, Limits & Misconceptions

Polyethylenimine Linear (PEI, MW 40,000) is primarily used for transient DNA and RNA delivery in in vitro settings. Major applications include:

• Gene function analysis via transient expression or knockdown.
• Recombinant protein production in mammalian cells at laboratory and pilot scale.
• Genome editing (CRISPR/Cas9) component delivery in cell culture.

It is not recommended for in vivo gene delivery due to rapid clearance and toxicity concerns. PEI’s efficacy depends on precise optimization of DNA:PEI ratio, cell density, and media conditions. For a detailed mechanistic comparison with other cationic polymers and advanced troubleshooting, see "Translating Mechanism to Impact: Polyethylenimine Linear ..." (this article details practical strategies not covered in the present review).

Common Pitfalls or Misconceptions

• PEI is not universally non-toxic: Excess PEI (>20:1 N/P ratio) can cause rapid cell death (Roach 2024).
• Not suited for in vivo gene therapy: Systemic use is limited by toxicity and non-specific distribution (Roach 2024).
• Branched and linear PEI differ: Only linear PEI (MW 40,000) should be used for protocols validated here (MoleculeProbe 2023).
• Serum compatibility varies: Lot-to-lot serum variation may reduce efficiency; optimization is advised.
• Not all cell types respond identically: Some primary cells or stem cells require alternative reagents or electroporation.

Workflow Integration & Parameters

The K1029 kit from APExBIO provides Polyethylenimine Linear (PEI, MW 40,000) at 2.5 mg/mL. For typical 6-well plate transfection, 1–2 μg DNA is mixed with 3–6 μg PEI in 150 mM NaCl, incubated 10–20 min at room temperature, and added to cells at 50–80% confluence in serum-containing medium. For large-scale protein production, PEI-mediated protocols scale to 100 L bioreactors (APExBIO). Storage at -20°C is advised for long-term, and at 4°C for frequent use to prevent freeze–thaw degradation.

For troubleshooting and advanced protocol guidance, see "Polyethylenimine Linear: Optimizing Transient Gene Expression" (expands on scalability and troubleshooting steps).

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) remains a gold-standard DNA transfection reagent for in vitro studies, balancing high efficiency, scalability, and serum compatibility. The APExBIO K1029 kit is validated for reproducible performance. Ongoing research is refining PEI’s use with mRNA, CRISPR, and nanoparticle platforms (Roach 2024). For further mechanistic perspective and clinical translation opportunities, see "Polyethylenimine Linear (PEI, MW 40,000): Enabling Precision ..." (provides translational context beyond the present article).